Jitinder Wilkhu

455 citations
8 papers · 340 indexed · h-index 8
Topics
Advanced Drug Delivery Systems (5 papers)RNA Interference and Gene Delivery (4 papers)Lipid Membrane Structure and Behavior (3 papers)

In The Last Decade

Jitinder Wilkhu

8 papers receiving 330 citations

Peers

Jitinder Wilkhu
Comparison fields: 5 of 75
  • Molecular Biology 178
  • Pharmaceutical Science 143
  • Biomaterials 74
  • Immunology 52
  • Organic Chemistry 37
Replace Shuichi Ando with:
Shuichi Ando Japan
Priyanka Prabhu India
Lalit Kumar India
Narendra Lariya India
M. S. Sudheesh India
S. B. Kulkarni United States
Sakib Yousaf United Kingdom
Diky Mudhakir Indonesia
Ruba Bnyan United Kingdom
Carlo Durrer France
Jitinder Wilkhu relative to Shuichi Ando Japan Shuichi Ando's profile →
Citations per field
00.5×3.1×
Shuichi Ando · 1×
Citations per year

Countries citing papers authored by Jitinder Wilkhu

Since Specialization
Citations

This map shows the geographic impact of Jitinder Wilkhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jitinder Wilkhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jitinder Wilkhu more than expected).

Fields of papers citing papers by Jitinder Wilkhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jitinder Wilkhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jitinder Wilkhu. The network helps show where Jitinder Wilkhu may publish in the future.

Co-authorship network of co-authors of Jitinder Wilkhu

This figure shows the co-authorship network connecting the top 25 collaborators of Jitinder Wilkhu. A scholar is included among the top collaborators of Jitinder Wilkhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jitinder Wilkhu. Jitinder Wilkhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 20
2 31
3 38
4 74
5 8
6 27
7 39
8 103

About Jitinder Wilkhu

Jitinder Wilkhu is a scholar working on Pharmaceutical Science, Immunology and Molecular Biology, having authored 8 papers that have together received 340 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), RNA Interference and Gene Delivery (4 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Pharmaceutical Science (143 citations), Biomaterials (74 citations) and Molecular Biology (178 citations). Jitinder Wilkhu has collaborated with scholars based in United Kingdom, Denmark and Spain. Frequent co-authors include Yvonne Perrie, Sarah E. McNeil, David E. Anderson, Dennis Christensen, Randip Kaur, Malou Henriksen‐Lacey, Afzal R. Mohammed, Daniel Kirby, Eric Lattmann and Sagida Bibi. Their work appears in journals such as International Journal of Pharmaceutics, Molecular Pharmaceutics and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026